Laura Brege's Net Worth
Estimate Recalculated Nov 7, 2024 04:47PM EST
Who is Laura Brege
Laura Brege has an estimated net worth of $12.5 Million. This is based on reported shares across multiple companies, which include Pacira BioSciences, Inc., DYNAVAX TECHNOLOGIES CORP, Edgewise Therapeutics, Inc., Mirum Pharmaceuticals, Inc., ACADIA PHARMACEUTICALS INC, ARATANA THERAPEUTICS, INC., DELCATH SYSTEMS INC, ANGIOTECH PHARMACEUTICALS INC, ONYX PHARMACEUTICALS INC, and PORTOLA PHARMACEUTICALS INC.
SEC CIK
Laura Brege's CIK is 0001365619
Past Insider Trading and Trends
2008 was Laura Brege's most active year for acquiring shares with 11 total transactions. Laura Brege's most active month to acquire stocks was the month of May. 2007 was Laura Brege's most active year for disposing of shares, totalling 21 transactions. Laura Brege's most active month to dispose stocks was the month of July. 2007 saw Laura Brege paying a total of $772,000.00 for 130,000 shares, this is the most they've acquired in one year. In 2013 Laura Brege cashed out on 200,540 shares for a total of $2,301,312.65, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
